Percutaneous Coronary Intervention
"Percutaneous Coronary Intervention" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of percutaneous techniques that are used to manage CORONARY OCCLUSION, including standard balloon angioplasty (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY), the placement of intracoronary STENTS, and atheroablative technologies (e.g., ATHERECTOMY; ENDARTERECTOMY; THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY). PTCA was the dominant form of PCI, before the widespread use of stenting.
| Descriptor ID |
D062645
|
| MeSH Number(s) |
E04.100.814.529.968 E04.502.382.968
|
| Concept/Terms |
Percutaneous Coronary Intervention- Percutaneous Coronary Intervention
- Coronary Intervention, Percutaneous
- Coronary Interventions, Percutaneous
- Intervention, Percutaneous Coronary
- Interventions, Percutaneous Coronary
- Percutaneous Coronary Interventions
- Percutaneous Coronary Revascularization
- Coronary Revascularization, Percutaneous
- Coronary Revascularizations, Percutaneous
- Percutaneous Coronary Revascularizations
- Revascularization, Percutaneous Coronary
- Revascularizations, Percutaneous Coronary
|
Below are MeSH descriptors whose meaning is more general than "Percutaneous Coronary Intervention".
Below are MeSH descriptors whose meaning is more specific than "Percutaneous Coronary Intervention".
This graph shows the total number of publications written about "Percutaneous Coronary Intervention" by people in this website by year, and whether "Percutaneous Coronary Intervention" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 3 | 2 | 5 |
| 2013 | 16 | 2 | 18 |
| 2014 | 9 | 6 | 15 |
| 2015 | 11 | 1 | 12 |
| 2016 | 12 | 3 | 15 |
| 2017 | 6 | 3 | 9 |
| 2018 | 9 | 0 | 9 |
| 2019 | 6 | 2 | 8 |
| 2020 | 8 | 0 | 8 |
| 2021 | 9 | 0 | 9 |
| 2022 | 7 | 1 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Percutaneous Coronary Intervention" by people in Profiles.
-
Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 02; 8(8):777-785.
-
Biomarker-Based Prediction of Recurrent?Ischemic Events in Patients With Acute Coronary Syndromes. J Am Coll Cardiol. 2022 11 01; 80(18):1735-1747.
-
External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry. Int J Cardiol. 2023 Jan 01; 370:51-57.
-
Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial. Eur Heart J Acute Cardiovasc Care. 2022 Jun 07; 11(4):336-349.
-
Impact of machine-learning-based coronary computed tomography angiography-derived fractional flow reserve on decision-making in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Radiol. 2022 Sep; 32(9):6008-6016.
-
Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCI. Am Heart J. 2022 07; 249:23-33.
-
Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION. Circ Cardiovasc Interv. 2022 Mar; 15(3):e011069.
-
Diagnosis and Treatment of Acute Coronary Syndromes: A Review. JAMA. 2022 Feb 15; 327(7):662-675.
-
Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX. Circ Cardiovasc Interv. 2022 01; 15(1):e010390.
-
Incidence of Myocardial Infarction Types in Patients Treated With Ticagrelor in the THEMIS Trial. Circ Cardiovasc Interv. 2021 12; 14(12):e011035.